Medical Procedure News

RSS

HUCPVC cell therapy more effective in restoring heart function after myocardial infarction

A study published this month by researchers at the University of Toronto and Toronto's Princess Margaret Hospital has shown that cells derived from the umbilical cord, "Human Umbilical Cord PeriVascular Cells" (HUCPVCs), are more effective in restoring heart function after an acute myocardial infarction (in common parlance, a heart attack) in a pre-clinical model than a similar cell population derived from bone marrow.

16 Nov 2012

First HSS medical symposium to take place in Rio de Janeiro from Nov. 28-29

The first medical symposium in Brazil presented by Hospitalys Ortopedia in Rio de Janeiro and New York City's Hospital for Special Surgery (HSS) will take place November 28 and 29 in Rio de Janeiro.

16 Nov 2012

Researchers develop catheter that can perform triple-duty during cardiac ablation surgery

Researchers at the McCormick School of Engineering are part of a team that has used stretchable electronics to create a multipurpose medical catheter that can both monitor heart functions and perform corrections on heart tissue during surgery.

16 Nov 2012

Study looks at health outcomes of kidney transplant recipients with low donor-specific antibodies

Kidney transplant recipients who have even very low levels of preformed antibodies directed against a donated kidney have a significantly increased risk of organ rejection and kidney failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

16 Nov 2012

Cook receives FDA approval for Zilver PTX Drug-Eluting Peripheral Stent to treat PAD

The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent), the first drug-eluting stent indicated to re-open a particular artery in the thigh (femoropopliteal artery) when narrowed or blocked as a result of peripheral artery disease (PAD).

15 Nov 2012

RXi announces pharmacokinetic results from RXI-109 Phase 1 study in healthy subjects

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the pharmacokinetic results of their single dose Phase 1 study with RXI-109 in healthy subjects.

15 Nov 2012

Breakthrough treatment for survivors of traumatic brain injury

The first treatment breakthrough of its kind for survivors of traumatic brain injury (TBI) or stroke will be published in the December 1 issue of the journal CNS Drugs, with an accompanying editorial.

15 Nov 2012

Hospitals directed to step up protections for kidney donors

Addressing long-held concerns about whether organ donors have adequate protections, the country's transplant regulators acted late Monday to require that hospitals thoroughly inform living kidney donors of the risks they face, fully evaluate their medical and psychological suitability, and then track their health for two years after donation.

15 Nov 2012

Antibody-coated stents carry increased risk of myocardial infarction and re-operation

If narrowed or blocked coronary vessels have to be widened or opened, a vascular support (stent) is usually inserted. Drug-coated stents are preferred for patients at high risk of renewed narrowing of vessels (restenosis). However, the use of antibody-coated stents has been increasing in recent years. Current studies provide indications that these new antibody-coated stents more frequently lead to myocardial infarction and make re-operation necessary.

15 Nov 2012

Hydrus stent may significantly reduce eye pressure in glaucoma patients

A tiny medical device no larger than an eyelash may significantly reduce eye pressure in glaucoma patients and allow some to stop using eye-drop medications, according to year-one clinical trial results for the device.

14 Nov 2012

Heart attack centres play a vital role in saving patients’ lives

Recent studies questioning the role of specialist heart attack centres produced misleading results because doctors tend to send the sickest patients to have the best care, according to new research.

14 Nov 2012

Study evaluates benefits of HBO2 therapy on post-concussion symptoms in military personnel with TBI

The average incidence of traumatic brain injury (TBI) among service members deployed in Middle East conflict zones has increased 117% in recent years, mainly due to proximity to explosive blasts. Therapeutic exposure to a high oxygen environment was hoped to minimize the concussion symptoms resulting from mild TBI, but hyperbaric oxygen (HBO2) treatment may not offer significant advantages, according to an article in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

14 Nov 2012

Could lactate levels in amniotic fluid help diagnose dysfunctional labour?

With as many as a 30 percent of pregnant women in Australia experiencing a caesarean birth, a study led by researchers from the University of Sydney aims to determine if there is a link between high levels of lactate in amniotic fluid and difficult labours which may end with a caesarean section.

13 Nov 2012

Radiotherapy protocol deviations: an interview with Dr Nitin Ohri

Radiotherapy is a key component of cancer therapy. A majority of cancer patients get radiotherapy in some form at some point in their disease course. It can be used in a curative setting or in a palliative setting.

12 Nov 2012

Patients more likely to develop ischemic stroke after total hip replacement surgeries

An international study involving the University of Southampton has shown people who undergo a total hip replacement are at a higher risk of a stroke in the first two weeks after surgery.

9 Nov 2012

ACT announces results from three ongoing stem cell clinical trials for macular degeneration

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that its upcoming conference call on its third quarter financial results will also provide some representative examples of data being collected from patients in its clinical trials for forms of macular degeneration.

9 Nov 2012

Women with ovarian cancer have superior outcomes after surgery at high-volume hospitals

A study by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia University Medical Center, recently e-published ahead of print by the Journal of Clinical Oncology, suggests that women who have surgery for ovarian cancer at high-volume hospitals have superior outcomes than similar patients at low-volume hospitals.

9 Nov 2012

Omeros to present results from first pivotal Phase 3 trial of OMS302 at AAO annual meeting

Omeros Corporation today reported that it will present data from its first pivotal Phase 3 clinical trial evaluating OMS302 at the American Academy of Ophthalmology (AAO) Annual Meeting, which will take place from November 10 through November 13 in Chicago, Illinois.

9 Nov 2012

Mastoscopic axillary lymph node dissection can reduce breast cancer complications

Axillary lymph node dissection is done in conjunction with lumpectomy or mastectomy to determine if breast cancer has spread to the adjoining lymph nodes. The conventional surgical approach leaves a surgical scar that is unattractive and can restrict range of motion in the shoulder joint. Also, squeezing and pulling the tumor during the breast operation can stimulate tumor cell metastases.

9 Nov 2012

International Day of Radiology marks 117th anniversary of X-ray discovery

International Day of Radiology — November 8, 2012 — marks the 117th anniversary of the discovery of the X-ray and the tremendous advances in patient care made possible by radiation therapy and medical imaging exams, such as MRI and CT scans. It is also a reminder that Congress needs to pass the Diagnostic Imaging Services Access Protection Act (H.R. 3269/ S. 2347) and halt drastic cuts in Medicare funding for imaging scans. This vital legislation would preserve ready access to lifesaving imaging care and may help reduce harm to seniors already resulting from cutbacks.

8 Nov 2012

Medical Procedure News

HUCPVC cell therapy more effective in restoring heart function after myocardial infarction

First HSS medical symposium to take place in Rio de Janeiro from Nov. 28-29

Researchers develop catheter that can perform triple-duty during cardiac ablation surgery

Study looks at health outcomes of kidney transplant recipients with low donor-specific antibodies

Cook receives FDA approval for Zilver PTX Drug-Eluting Peripheral Stent to treat PAD

RXi announces pharmacokinetic results from RXI-109 Phase 1 study in healthy subjects

Breakthrough treatment for survivors of traumatic brain injury

Hospitals directed to step up protections for kidney donors

Antibody-coated stents carry increased risk of myocardial infarction and re-operation

Hydrus stent may significantly reduce eye pressure in glaucoma patients

Heart attack centres play a vital role in saving patients’ lives

Study evaluates benefits of HBO2 therapy on post-concussion symptoms in military personnel with TBI

Could lactate levels in amniotic fluid help diagnose dysfunctional labour?

Radiotherapy protocol deviations: an interview with Dr Nitin Ohri

Patients more likely to develop ischemic stroke after total hip replacement surgeries

ACT announces results from three ongoing stem cell clinical trials for macular degeneration

Women with ovarian cancer have superior outcomes after surgery at high-volume hospitals

Omeros to present results from first pivotal Phase 3 trial of OMS302 at AAO annual meeting

Mastoscopic axillary lymph node dissection can reduce breast cancer complications

International Day of Radiology marks 117th anniversary of X-ray discovery

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News